Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data

Total article views   Abstract views HTML views PDF downloads Totals
10,914 Dovepress* 8,150 607+ 1,406 8,757
PubMed Central* 2 2,155 320 2,157
Totals 8,152 2,762 1,726 10,914
*Since 20 June 2012
+Since July 2016

View citations on PubMed Central and Google Scholar